![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (119)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Enrico Capuzzi, Alice Caldiroli, Veronica Ciscato, Stefania Russo & Massimiliano Buoli. (2021) Experimental Serotonergic Agents for the Treatment of Schizophrenia. Journal of Experimental Pharmacology 13, pages 49-67.
Read now
Read now
Piotr Stępnicki, Magda Kondej, Oliwia Koszła, Justyna Żuk & Agnieszka A. Kaczor. (2021) Multi-targeted drug design strategies for the treatment of schizophrenia. Expert Opinion on Drug Discovery 16:1, pages 101-114.
Read now
Read now
Vanessa Haller, Philipp Nahidino, Michael Forster & Stefan A. Laufer. (2020) An updated patent review of p38 MAP kinase inhibitors (2014-2019). Expert Opinion on Therapeutic Patents 30:6, pages 453-466.
Read now
Read now
Deepak Perumal, Areejit Samal, Kishore R. Sakharkar & Meena K. Sakharkar. (2011) Targeting multiple targets in Pseudomonas aeruginosa PAO1 using flux balance analysis of a reconstructed genome-scale metabolic network. Journal of Drug Targeting 19:1, pages 1-13.
Read now
Read now
V.P. Veerapur, K.R. Prabhakar, M.R. Kandadi, K.K. Srinivasan & M.K. Unnikrishnan. (2010) Antidiabetic effect of Dodonaea viscosa aerial parts in high fat diet and low dose streptozotocin-induced type 2 diabetic rats: A mechanistic approach. Pharmaceutical Biology 48:10, pages 1137-1148.
Read now
Read now
Donavon C Hiss & Gary A Gabriels. (2009) Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part II: targeting cell cycle events, caspases, NF-κB and the proteasome. Expert Opinion on Drug Discovery 4:9, pages 907-921.
Read now
Read now
Articles from other publishers (113)
Sven Marcel Stefan & Muhammad Rafehi. (2023) Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development. Drug Development Research.
Crossref
Crossref
Jubie Selvaraj, Motamarri Venkata Naga Lalitha Chaitanya, Akey Krishna Swaroop, Prabha Thangavelu & Rashmi Saxena Pal. 2023. Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach. Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach
122
138
.
Samuel J. Santos, Fernanda C. P. Rossatto, Natália S. Jardim, Daiana S. Ávila, Rodrigo Ligabue-Braun, Luiz A. M. Fontoura, Karine R. Zimmer & Dennis Russowsky. (2023) Chromene-dihydropyrimidinone and xanthene-dihydropyrimidinone hybrids: design, synthesis, and antibacterial and antibiofilm activities. New Journal of Chemistry 47:16, pages 7500-7520.
Crossref
Crossref
Elise Koch, Karolina Kauppi & Chi-Hua Chen. (2023) Candidates for drug repurposing to address the cognitive symptoms in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 120, pages 110637.
Crossref
Crossref
V. V. Belakhov. (2023) Polyfunctional Drugs: Search, Development, Use in Medical Practice, and Environmental Aspects of Preparation and Application (A Review). Russian Journal of General Chemistry 92:13, pages 3030-3055.
Crossref
Crossref
Chuan Li, Wei-wei Jia, Jun-ling Yang, Chen Cheng & Olajide E. Olaleye. (2022) Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines. Acta Pharmacologica Sinica 43:12, pages 3080-3095.
Crossref
Crossref
Camille Hauguel, Sarah Ducellier, Olivier Provot, Nada Ibrahim, Diana Lamaa, Coline Balcerowiak, Boris Letribot, Megane Nascimento, Vincent Blanchard, Laurie Askenatzis, Helene Levaique, Jérôme Bignon, Francesco Baschieri, Cyril Bauvais, Guillaume Bollot, Dolor Renko, Alain Deroussent, Bastien Prost, Marie-Catherine Laisne, Sophie Michallet, Laurence Lafanechère, Sébastien Papot, Guillaume Montagnac, Christine Tran, Mouad Alami, Sebastien Apcher & Abdallah Hamze. (2022) Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors. European Journal of Medicinal Chemistry 240, pages 114573.
Crossref
Crossref
Bengisu Turgutalp, Prabesh Bhattarai, Tugba Ercetin, Chiara Luise, Rengin Reis, Enise Ece Gurdal, Andreas Isaak, Derya Biriken, Elisabeth Dinter, Hande Sipahi, Dirk Schepmann, Anna Junker, Bernhard Wünsch, Wolfgang Sippl, Hayrettin Ozan Gulcan, Caghan Kizil & Mine Yarim. (2022) Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer’s Disease. Journal of Medicinal Chemistry 65:18, pages 12292-12318.
Crossref
Crossref
Elise Koch & Ditte Demontis. (2022) Drug repurposing candidates to treat core symptoms in autism spectrum disorder. Frontiers in Pharmacology 13.
Crossref
Crossref
DR Richardson, M Gholam Azad, R Afroz, V Richardson & M Dharmasivam. (2022) Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia. Future Medicinal Chemistry 14:13, pages 1005-1017.
Crossref
Crossref
Fatima Noor, Muhammad Tahir ul Qamar, Usman Ali Ashfaq, Aqel Albutti, Ameen S. S. Alwashmi & Mohammad Abdullah Aljasir. (2022) Network Pharmacology Approach for Medicinal Plants: Review and Assessment. Pharmaceuticals 15:5, pages 572.
Crossref
Crossref
Thomas Blaschke & Jürgen Bajorath. (2021) Fine-tuning of a generative neural network for designing multi-target compounds. Journal of Computer-Aided Molecular Design 36:5, pages 363-371.
Crossref
Crossref
Xiaobo Liu, Yuzhen Li, Qian Zhang, Qingshan Pan, Pengwu Zheng, Xinyang Dai, Zhaoshi Bai & Wufu Zhu. (2022) Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors. Frontiers in Chemistry 10.
Crossref
Crossref
Vishal S. Patil, Darasaguppe R. Harish, Umashankar Vetrivel, Subarna Roy, Sanjay H. Deshpande & Harsha V. Hegde. (2022) Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from Terminalia chebula: A Structural Perspective. Molecules 27:3, pages 1076.
Crossref
Crossref
Lucas Caruso, Nathalia Fonseca Nadur, Marina Brandão da Fonseca, Larissa de Almeida Peixoto Ferreira, Renata Barbosa Lacerda, Cedric Stephan Graebin & Arthur Eugen Kümmerle. (2022) The Design of Multi-target Drugs to Treat Cardiovascular Diseases: Two
(or more) Birds on One Stone. Current Topics in Medicinal Chemistry 22:5, pages 366-394.
Crossref
Crossref
Ladan Pourabdi, Tuba Tüylü Küçükkılınç, Fatemeh Khoshtale, Beyza Ayazgök, Hamid Nadri, Farid Farokhi Alashti, Hamid Forootanfar, Tayebeh Akbari, Mohammad Shafiei, Alireza Foroumadi, Mohammad Sharifzadeh, Mehdi Shafiee Ardestani, M. Saeed Abaee, Loghman Firoozpour, Mehdi Khoobi & Mohammad M. Mojtahedi. (2022) Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’s Disease. Frontiers in Chemistry 9.
Crossref
Crossref
Chu Xin Ng, Cheng Foh Le, Yin Sim Tor & Sau Har Lee. (2021) Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways. International Journal of Peptide Research and Therapeutics 27:4, pages 2757-2775.
Crossref
Crossref
Anubhuti Jha, Archana Vimal & Awanish Kumar. (2021) Target shortage and less explored multiple targeting: hurdles in the development of novel antifungals but overcome/addressed effectively through structural bioinformatics. Briefings in Bioinformatics 22:4.
Crossref
Crossref
Francesca Serena Abatematteo, Mauro Niso, Marialessandra Contino, Marcello Leopoldo & Carmen Abate. (2021) Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives. International Journal of Molecular Sciences 22:12, pages 6359.
Crossref
Crossref
Wu-Yingzheng Guo, Yi-Xuan Fu, Shi-Yu Liu, Long-Can Mei, Yao Sun, Jun Yin, Wen-Chao Yang & Guang-Fu Yang. (2021) Multienzyme-Targeted Fluorescent Probe as a Biosensing Platform for Broad Detection of Pesticide Residues. Analytical Chemistry 93:18, pages 7079-7085.
Crossref
Crossref
Dariusz Nowicki, Klaudyna Krause, Patrycja Szamborska, Adrianna Żukowska, Grzegorz M. Cech & Agnieszka Szalewska-Pałasz. (2021) Induction of the Stringent Response Underlies the Antimicrobial Action of Aliphatic Isothiocyanates. Frontiers in Microbiology 11.
Crossref
Crossref
Weidong Zhang & Jing Zhao. 2021. Network Pharmacology. Network Pharmacology
247
320
.
Mahnoor Patel, M. Amin-ul Mannan & Banhishikha Datta. 2021. Integrated Omics Approaches to Infectious Diseases. Integrated Omics Approaches to Infectious Diseases
139
155
.
Maycon D. de Oliveira, Jéssica de O. Araújo, João M.P. Galúcio, Kauê Santana & Anderson H. Lima. (2020) Targeting shikimate pathway: In silico analysis of phosphoenolpyruvate derivatives as inhibitors of EPSP synthase and DAHP synthase. Journal of Molecular Graphics and Modelling 101, pages 107735.
Crossref
Crossref
Nikita Kanbarkar, Sanjay Mishra & Pukar Khanal. (2020) Beneficial effect of phospholipase A2 group IIA inhibitors from Acacia suma in obesity: an in silico and in vitro study. Advances in Traditional Medicine 20:4, pages 599-608.
Crossref
Crossref
Diba Sheipouri, Casey I. Gallagher, Susan Shimmon, Tristan Rawling & Robert J. Vandenberg. (2020) A System for Assessing Dual Action Modulators of Glycine Transporters and Glycine Receptors. Biomolecules 10:12, pages 1618.
Crossref
Crossref
Hua Cheng, Hong-Fu Liu, Lu Yang, Rui Zhang, Cheng Chen, Yuan Wu & Wen Jiang. (2020) N-(3,5-Dichloro-4-(2,4,6-trichlorophenoxy)phenyl)benzenesulfonamide: A new dual-target inhibitor of mitochondrial complex II and complex III via structural simplification. Bioorganic & Medicinal Chemistry 28:5, pages 115299.
Crossref
Crossref
Yaxia Yuan, Jianfeng Pei & Luhua Lai. (2020) LigBuilder V3: A Multi-Target de novo Drug Design Approach. Frontiers in Chemistry 8.
Crossref
Crossref
Vimal K. Madduluri & Ajay K. Sah. (2020)
Synthesis of Mefenamic Acid Containing
N
‐Glycoconjugates and Their Evaluation as Human COX‐2 Enzyme Inhibitor
. ChemistrySelect 5:7, pages 2197-2200.
Crossref
Crossref
Žiga Skok, Nace Zidar, Danijel Kikelj & Janez Ilaš. (2019) Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets. Journal of Medicinal Chemistry 63:3, pages 884-904.
Crossref
Crossref
Jonathan Gressel. (2019) Perspective: present pesticide discovery paradigms promote the evolution of resistance – learn from nature and prioritize multi‐target site inhibitor design. Pest Management Science 76:2, pages 421-425.
Crossref
Crossref
John W. Babich & Uwe Haberkorn. 2020. Philosophy of Advanced Medical Imaging. Philosophy of Advanced Medical Imaging
67
80
.
Anubhuti Jha & Awanish Kumar. (2019) Anticandidal agent for multiple targets: the next paradigm in the discovery of proficient therapeutics/overcoming drug resistance. Future Medicinal Chemistry 11:22, pages 2955-2974.
Crossref
Crossref
H Syukor & A B Sakhinah. (2019) Characterization of Essential Protein in Aging Based on Network Analysis. Journal of Physics: Conference Series 1366:1, pages 012026.
Crossref
Crossref
Federica De Leo, Giacomo Quilici, Mario Tirone, Francesco De Marchis, Valeria Mannella, Chiara Zucchelli, Alessandro Preti, Alessandro Gori, Maura Casalgrandi, Rosanna Mezzapelle, Marco E Bianchi & Giovanna Musco. (2019)
Diflunisal targets the
HMGB
1/
CXCL
12 heterocomplex and blocks immune cell recruitment
. EMBO reports 20:10.
Crossref
Crossref
Elena González-Hernández, Rubén Aparicio, Mercedes Garayoa, M. José Montero, M. Ángeles Sevilla & Concepción Pérez-Melero. (2019) Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents. MedChemComm 10:9, pages 1589-1598.
Crossref
Crossref
Luciana Scotti, Alex France Messias Monteiro, Jéssika de Oliveira Viana, Francisco Jaime Bezerra Mendonça Junior, Hamilton M. Ishiki, Ernestine Nkwengoua Tchouboun, Rodrigo Santos & Marcus Tullius Scotti. (2019) Multi-Target Drugs Against Metabolic Disorders. Endocrine, Metabolic & Immune Disorders - Drug Targets 19:4, pages 402-418.
Crossref
Crossref
Liangjun Yang, Wei Liu, Zhipeng Hu, Maoyi Yang, Jiali Li, Xiangzhen Fan & Huafeng Pan. (2019) A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action of the Wei Pi Xiao Decoction for the Treatment of Gastric Precancerous Lesions. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-15.
Crossref
Crossref
Ewgenij Proschak, Holger Stark & Daniel Merk. (2018) Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds. Journal of Medicinal Chemistry 62:2, pages 420-444.
Crossref
Crossref
Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria E. Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez & Maria Laura Bolognesi. (2018) Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. Journal of Medicinal Chemistry 61:17, pages 7640-7656.
Crossref
Crossref
Yicheng Mei & Baowei Yang. (2018) Rational application of drug promiscuity in medicinal chemistry. Future Medicinal Chemistry 10:15, pages 1835-1851.
Crossref
Crossref
Stefan MichelfelderFriedericke FischerAstrid WäldinKim V. HörleMartin PohlJuliana Parsons, Ralf Reski, Eva L. Decker, Peter F. Zipfel, Christine Skerka & Karsten Häffner. (2018) The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential. Journal of the American Society of Nephrology 29:4, pages 1141-1153.
Crossref
Crossref
Yunierkis Perez-Castillo, Aminael Sánchez-Rodríguez, Eduardo Tejera, Maykel Cruz-Monteagudo, Fernanda Borges, M. Natália D. S. Cordeiro, Huong Le-Thi-Thu & Hai Pham-The. (2018) A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents. PLOS ONE 13:2, pages e0192176.
Crossref
Crossref
Sébastien Lacroix, Jasna Klicic Badoux, Marie-Pier Scott-Boyer, Silvia Parolo, Alice Matone, Corrado Priami, Melissa J. Morine, Jim Kaput & Sofia Moco. (2018) A computationally driven analysis of the polyphenol-protein interactome. Scientific Reports 8:1.
Crossref
Crossref
Jing Zhao, Dale G. Nagle, YuDong Zhou & Weidong Zhang. 2018. Systems Biology and its Application in TCM Formulas Research. Systems Biology and its Application in TCM Formulas Research
69
95
.
Pankaj K. Singh & Om Silakari. 2018. Key Heterocycle Cores for Designing Multitargeting Molecules. Key Heterocycle Cores for Designing Multitargeting Molecules
1
29
.
Sinoy Sugunan & G. K. Rajanikant. 2019. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Multi-Target Drug Design Using Chem-Bioinformatic Approaches
385
394
.
Manoj Kumar & Anuj Sharma. 2019. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Multi-Target Drug Design Using Chem-Bioinformatic Approaches
419
442
.
Nazar Ul Islam, Raza Amin, Muhammad Shahid, Muhammad Amin, Sumera Zaib & Jamshed Iqbal. (2017) A multi-target therapeutic potential of Prunus domestica gum stabilized nanoparticles exhibited prospective anticancer, antibacterial, urease-inhibition, anti-inflammatory and analgesic properties.. BMC Complementary and Alternative Medicine 17:1.
Crossref
Crossref
. 2017. Essential Oils and Nanotechnology for Treatment of Microbial Diseases. Essential Oils and Nanotechnology for Treatment of Microbial Diseases
143
158
.
James Schuler, Matthew Hudson, Diane Schwartz & Ram Samudrala. (2017) A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment. Molecules 22:10, pages 1777.
Crossref
Crossref
Krishna Kanhaiya, Eugen Czeizler, Cristian Gratie & Ion Petre. (2017) Controlling Directed Protein Interaction Networks in Cancer. Scientific Reports 7:1.
Crossref
Crossref
Thomas Efferth, Mohamed E.M. Saeed, Elhaj Mirghani, Awadh Alim, Zahir Yassin, Elfatih Saeed, Hassan E. Khalid & Salah Daak. (2017) Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget 8:30, pages 50284-50304.
Crossref
Crossref
Maykel Cruz-Monteagudo, Stephan Schürer, Eduardo Tejera, Yunierkis Pérez-Castillo, José L. Medina-Franco, Aminael Sánchez-Rodríguez & Fernanda Borges. (2017) Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery. Drug Discovery Today 22:7, pages 994-1007.
Crossref
Crossref
Miquel Duran-Frigola, Lydia Siragusa, Eytan Ruppin, Xavier Barril, Gabriele Cruciani & Patrick Aloy. (2017) Detecting similar binding pockets to enable systems polypharmacology. PLOS Computational Biology 13:6, pages e1005522.
Crossref
Crossref
Ying Wei, Pengshou Li, Bo Li, Jiaqi Gao, Dongchao Wang, Lingling Qin, Wen Sun, Yunling Xu, Haoxia Shi, Tunhai Xu & Tonghua Liu. (2017)
Study of the Hypoglycemic Activity of Derivatives of Isoflavones from
Cicer arietinum
L.
. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-18.
Crossref
Crossref
Giovanni Bottegoni & Andrea Cavalli. 2017. Design of Hybrid Molecules for Drug Development. Design of Hybrid Molecules for Drug Development
239
258
.
Priya Bawa, Priyamvada Pradeep, Pradeep Kumar, Yahya E. Choonara, Girish Modi & Viness Pillay. (2016) Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. Drug Discovery Today 21:12, pages 1886-1914.
Crossref
Crossref
Ming-Yu Wu, Gerard Esteban, Simone Brogi, Masahi Shionoya, Li Wang, Giuseppe Campiani, Mercedes Unzeta, Tsutomu Inokuchi, Stefania Butini & Jose Marco-Contelles. (2016) Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation. European Journal of Medicinal Chemistry 121, pages 864-879.
Crossref
Crossref
Paramasivan Poornima, Jothi Dinesh Kumar, Qiaoli Zhao, Martina Blunder & Thomas Efferth. (2016) Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature. Pharmacological Research 111, pages 290-302.
Crossref
Crossref
Mahesh Shidore, Jatin Machhi, Kaushik Shingala, Prashant Murumkar, Mayank Kumar Sharma, Neetesh Agrawal, Ashutosh Tripathi, Zalak Parikh, Prakash Pillai & Mange Ram Yadav. (2016) Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation. Journal of Medicinal Chemistry 59:12, pages 5823-5846.
Crossref
Crossref
Jean-Pierre Jourdan, Marc Since, Laïla El Kihel, Cédric Lecoutey, Sophie Corvaisier, Rémi Legay, Jana Sopkova-de Oliveira Santos, Thierry Cresteil, Aurélie Malzert-Fréon, Christophe Rochais & Patrick Dallemagne. (2016) Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment. European Journal of Medicinal Chemistry 114, pages 365-379.
Crossref
Crossref
Jinan Wang, Zihu Guo, Yingxue Fu, Ziyin Wu, Chao Huang, Chunli Zheng, Piar Ali Shar, Zhenzhong Wang, Wei Xiao & Yonghua Wang. (2016) Weak-binding molecules are not drugs?—toward a systematic strategy for finding effective weak-binding drugs. Briefings in Bioinformatics, pages bbw018.
Crossref
Crossref
Mahreen Arooj, Sugunadevi Sakkiah, Guang Ping Cao, Songmi Kim, Venkatesh Arulalapperumal & Keun Woo Lee. (2015) Finding off-targets, biological pathways, and target diseases for chymase inhibitors via structure-based systems biology approach. Proteins: Structure, Function, and Bioinformatics 83:7, pages 1209-1224.
Crossref
Crossref
Christophe Rochais, Cédric Lecoutey, Florence Gaven, Patrizia Giannoni, Katia Hamidouche, Damien Hedou, Emmanuelle Dubost, David Genest, Samir Yahiaoui, Thomas Freret, Valentine Bouet, François Dauphin, Jana Sopkova de Oliveira Santos, Céline Ballandonne, Sophie Corvaisier, Aurélie Malzert-Fréon, Remi Legay, Michel Boulouard, Sylvie Claeysen & Patrick Dallemagne. (2015)
Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT
4
R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride
. Journal of Medicinal Chemistry 58:7, pages 3172-3187.
Crossref
Crossref
Xiangjun Kong, Wenxia Zhou, Jian-Bo Wan, Qianru Zhang, Jingyun Ni & Yuanjia Hu. (2015) An Integrative Thrombosis Network: Visualization and Topological Analysis. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-9.
Crossref
Crossref
Yi-Yuan Chiu, Jen-Hu Tseng, Kuan-Hsiu Liu, Chih-Ta Lin, Kai-Cheng Hsu & Jinn-Moon Yang. (2014) Homopharma: A new concept for exploring the molecular binding mechanisms and drug repurposing. BMC Genomics 15:S9.
Crossref
Crossref
Chunli Zheng, Jinan Wang, Jianling Liu, Mengjie Pei, Chao Huang & Yonghua Wang. (2014) System-level multi-target drug discovery from natural products with applications to cardiovascular diseases. Molecular Diversity 18:3, pages 621-635.
Crossref
Crossref
Petra H. Pfisterer, Daniela Schuster, Judith M. Rollinger & Hermann Stuppner. 2006. Encyclopedia of Analytical Chemistry. Encyclopedia of Analytical Chemistry
1
18
.
Erchang Shang, Yaxia Yuan, Xinyi Chen, Ying Liu, Jianfeng Pei & Luhua Lai. (2014)
De Novo
Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy
. Journal of Chemical Information and Modeling 54:4, pages 1235-1241.
Crossref
Crossref
Umer Rashid & Farzana L. Ansari. 2014. Drug Design and Discovery in Alzheimer's Disease. Drug Design and Discovery in Alzheimer's Disease
40
141
.
Dávid Fazekas, Mihály Koltai, Dénes Türei, Dezső Módos, Máté Pálfy, Zoltán Dúl, Lilian Zsákai, Máté Szalay-Bekő, Katalin Lenti, Illés J Farkas, Tibor Vellai, Péter Csermely & Tamás Korcsmáros. (2013) SignaLink 2 – a signaling pathway resource with multi-layered regulatory networks. BMC Systems Biology 7:1.
Crossref
Crossref
Jens-Uwe Peters. (2013) Polypharmacology – Foe or Friend?. Journal of Medicinal Chemistry 56:22, pages 8955-8971.
Crossref
Crossref
Wei Ye Tao, Lai You Wang, Guo Quan Huang & Man Luo. (2013) Traditional Chinese Medicine Based on Network Pharmacology. Applied Mechanics and Materials 411-414, pages 3141-3145.
Crossref
Crossref
Feng Jin, Dan Gao, Qin Wu, Feng Liu, Yuzong Chen, Chunyan Tan & Yuyang Jiang. (2013) Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor. Bioorganic & Medicinal Chemistry 21:18, pages 5694-5706.
Crossref
Crossref
János Kubisch, Dénes Türei, László Földvári-Nagy, Zsuzsanna A. Dunai, Lilian Zsákai, Máté Varga, Tibor Vellai, Péter Csermely & Tamás Korcsmáros. (2013) Complex regulation of autophagy in cancer – Integrated approaches to discover the networks that hold a double-edged sword. Seminars in Cancer Biology 23:4, pages 252-261.
Crossref
Crossref
Peter Csermely, Tamás Korcsmáros, Huba J.M. Kiss, Gábor London & Ruth Nussinov. (2013) Structure and dynamics of molecular networks: A novel paradigm of drug discovery. Pharmacology & Therapeutics 138:3, pages 333-408.
Crossref
Crossref
Feng Jin, Dan Gao, Cunlong Zhang, Feng Liu, Bizhu Chu, Yan Chen, Yu Zong Chen, Chunyan Tan & Yuyang Jiang. (2013) Exploration of 1-(3-chloro-4-(4-oxo-4H-chromen-2-yl)phenyl)-3-phenylurea derivatives as selective dual inhibitors of Raf1 and JNK1 kinases for anti-tumor treatment. Bioorganic & Medicinal Chemistry 21:3, pages 824-831.
Crossref
Crossref
Hu Meng, Ying Liu, Yujing Zhai & Luhua Lai. (2013) Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase. European Journal of Medicinal Chemistry 59, pages 160-167.
Crossref
Crossref
Máté Pálfy, László Földvári-Nagy, Dezső Módos, Katalin Lenti & Tamás Korcsmáros. 2013. Systems Biology. Systems Biology
463
477
.
Antonio Mora & Ian M Donaldson. (2012) Effects of protein interaction data integration, representation and reliability on the use of network properties for drug target prediction. BMC Bioinformatics 13:1.
Crossref
Crossref
David Alvarez-Ponce & Mario A. Fares. (2012) Evolutionary Rate and Duplicability in the Arabidopsis thaliana Protein?Protein Interaction Network. Genome Biology and Evolution 4:12, pages 1263-1274.
Crossref
Crossref
Lei Zhang, Xiaojie Chen, Jun Liu, Qingzhang Zhu, Ying Leng, Xiaomin Luo, Hualiang Jiang & Hong Liu. (2012) Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase. European Journal of Medicinal Chemistry 58, pages 624-639.
Crossref
Crossref
Máté Pálfy, Attila Reményi & Tamás Korcsmáros. (2012) Endosomal crosstalk: meeting points for signaling pathways. Trends in Cell Biology 22:9, pages 447-456.
Crossref
Crossref
Feixiong Cheng, Yadi Zhou, Weihua Li, Guixia Liu & Yun Tang. (2012) Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method. PLoS ONE 7:7, pages e41064.
Crossref
Crossref
Subhash Ajmani & Sudhir A. Kulkarni. (2012) Application of GQSAR for Scaffold Hopping and Lead Optimization in Multitarget Inhibitors. Molecular Informatics 31:6-7, pages 473-490.
Crossref
Crossref
Diána Papp, Katalin Lenti, Dezső Módos, Dávid Fazekas, Zoltán Dúl, Dénes Türei, László Földvári-Nagy, Ruth Nussinov, Péter Csermely & Tamás Korcsmáros. (2012) The NRF2‐related interactome and regulome contain multifunctional proteins and fine‐tuned autoregulatory loops. FEBS Letters 586:13, pages 1795-1802.
Crossref
Crossref
Min-Hee Pang, Yuntae Kim, Kyung Woon Jung, Sunyoung Cho & Doo H. Lee. (2012) A series of case studies: practical methodology for identifying antinociceptive multi-target drugs. Drug Discovery Today 17:9-10, pages 425-434.
Crossref
Crossref
Andrew L. Hopkins. 2012. Polypharmacology in Drug Discovery. Polypharmacology in Drug Discovery
1
6
.
Lei XieLi XieSarah L. Kinnings & Philip E. Bourne. (2012) Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs. Annual Review of Pharmacology and Toxicology 52:1, pages 361-379.
Crossref
Crossref
Giovanni Bottegoni, Angelo D. Favia, Maurizio Recanatini & Andrea Cavalli. (2012) The role of fragment-based and computational methods in polypharmacology. Drug Discovery Today 17:1-2, pages 23-34.
Crossref
Crossref
Ashraf A. Khalil, Nihal F. Kabapy, Sahar F. Deraz & Christopher Smith. (2011) Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1816:2, pages 89-104.
Crossref
Crossref
Corrado TringaliJudith Rollinger & Gerhard Wolber. 2011. Bioactive Compounds from Natural Sources, Second Edition. Bioactive Compounds from Natural Sources, Second Edition
97
132
.
Illés J. FarkasTamás KorcsmárosIstván A. KovácsÁgoston MihalikRobin PalotaiGábor I. SimkóKristóf Z. SzalayMáté Szalay-BekőTibor VellaiShijun WangPeter Csermely. (2011) Network-Based Tools for the Identification of Novel Drug TargetsAdapted from the opening presentation at the International Conference on Systems Biology of Human Disease (SBHD) in Boston, Massachusetts, 16 to 18 June 2010.. Science Signaling 4:173.
Crossref
Crossref
Qian Li, Xudong Li, Canghai Li, Lirong Chen, Jun Song, Yalin Tang & Xiaojie Xu. (2011) A Network-Based Multi-Target Computational Estimation Scheme for Anticoagulant Activities of Compounds. PLoS ONE 6:3, pages e14774.
Crossref
Crossref
Huaming Sheng & Hongbin Sun. (2011) Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases. Natural Product Reports 28:3, pages 543.
Crossref
Crossref
Anton F. Fliri, William T. Loging & Robert A. Volkmann. (2010) Cause-effect relationships in medicine: a protein network perspective. Trends in Pharmacological Sciences 31:11, pages 547-555.
Crossref
Crossref
Tamás Korcsmáros, Illés J. Farkas, Máté S. Szalay, Petra Rovó, Dávid Fazekas, Zoltán Spiró, Csaba Böde, Katalin Lenti, Tibor Vellai & Péter Csermely. (2010) Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discovery. Bioinformatics 26:16, pages 2042-2050.
Crossref
Crossref
Fereydoun HormozdiariRaheleh SalariVineet BafnaS. Cenk Sahinalp. (2010) Protein-Protein Interaction Network Evaluation for Identifying Potential Drug Targets. Journal of Computational Biology 17:5, pages 669-684.
Crossref
Crossref
André Schrattenholz, Karlfried Groebe & Vukic Soskic. 2010. Systems Biology in Drug Discovery and Development. Systems Biology in Drug Discovery and Development
29
58
.
Maria Laura Bolognesi, Andrea Cavalli, Christian Bergamini, Romana Fato, Giorgio Lenaz, Michela Rosini, Manuela Bartolini, Vincenza Andrisano & Carlo Melchiorre. (2009) Toward a Rational Design of Multitarget-Directed Antioxidants: Merging Memoquin and Lipoic Acid Molecular Frameworks. Journal of Medicinal Chemistry 52:23, pages 7883-7886.
Crossref
Crossref
Arthur M Doweyko & Lidia M Doweyko. (2009) What is next for small-molecule drug discovery?. Future Medicinal Chemistry 1:6, pages 1029-1036.
Crossref
Crossref
Maria L Bolognesi, Riccardo Matera, Anna Minarini, Michela Rosini & Carlo Melchiorre. (2009) Alzheimer's disease: new approaches to drug discovery. Current Opinion in Chemical Biology 13:3, pages 303-308.
Crossref
Crossref
Sylvie Barch?chath, Christopher Williams, Khalil Saade, Sylvia Lauwagie & Bertrand Jean-Claude. (2009) Rational Design of Multitargeted Tyrosine Kinase Inhibitors: A Novel Approach. Chemical Biology & Drug Design 73:4, pages 380-387.
Crossref
Crossref
Judith M. Rollinger. (2009) Accessing target information by virtual parallel screening—The impact on natural product research. Phytochemistry Letters 2:2, pages 53-58.
Crossref
Crossref
Dengguo Wei, Xiaolu Jiang, Lu Zhou, Jing Chen, Zheng Chen, Chong He, Kun Yang, Ying Liu, Jianfeng Pei & Luhua Lai. (2008) Discovery of Multitarget Inhibitors by Combining Molecular Docking with Common Pharmacophore Matching. Journal of Medicinal Chemistry 51:24, pages 7882-7888.
Crossref
Crossref
Jose C Nacher & Jean-Marc Schwartz. (2008) A global view of drug-therapy interactions. BMC Pharmacology 8:1.
Crossref
Crossref
Andrew L Hopkins. (2008) Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 4:11, pages 682-690.
Crossref
Crossref
L. Michel Espinoza-Fonseca. (2008) Knowledgebase for addiction-related genes: Is it possible an extrapolation to rational multi-target drug design?. Bioorganic & Medicinal Chemistry 16:20, pages 9346-9348.
Crossref
Crossref
Sten Ohlson. (2008) Designing transient binding drugs: A new concept for drug discovery. Drug Discovery Today 13:9-10, pages 433-439.
Crossref
Crossref
Kun Yang, Hongjun Bai, Qi Ouyang, Luhua Lai & Chao Tang. (2008) Finding multiple target optimal intervention in disease‐related molecular network. Molecular Systems Biology 4:1.
Crossref
Crossref
David A. Winkler. 2008.
143
170
.
Robin Palotai, Máté S. Szalay & Péter Csermely. (2007) Chaperones as integrators of cellular networks: Changes of cellular integrity in stress and diseases. IUBMB Life 60:1, pages 10-18.
Crossref
Crossref